| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 2 | 2 | 4 |
| Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| estrogen nuclear receptor alpha | 16 | 0 | 0 | 16 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 0 | 1 | 1 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 9 | 0 | 0 | 9 |
| euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 5 | 0 | 0 | 5 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 5 | 0 | 0 | 5 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 3 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 10 | 0 | 0 | 10 |
| GLI family zinc finger 3 | 13 | 0 | 0 | 13 |
| AR protein | 14 | 0 | 0 | 14 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
| IDH1 | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 14 | 0 | 0 | 14 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| geminin | 5 | 0 | 0 | 5 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 2 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 4 | 0 | 0 | 4 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 4 | 0 | 0 | 4 |
| TDP1 protein | 5 | 0 | 0 | 5 |
| TSHR protein | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Alpha-synuclein | 4 | 0 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Arginase | 0 | 2 | 0 | 2 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 1 | 0 | 7 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 7 | 0 | 7 |
| Prostaglandin G/H synthase 1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 6 | 0 | 6 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 1 | 2 | 0 | 3 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Smad3 | 2 | 0 | 0 | 2 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| PAX8 | 0 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| PINK1 | 1 | 0 | 0 | 1 |
| G | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| Parkin | 1 | 0 | 0 | 1 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| caspase-3 | 4 | 0 | 0 | 4 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| Histone H2A.x | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 2 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| perilipin-5 | 0 | 2 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
| perilipin-1 | 0 | 2 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
| protein AF-9 isoform a | 0 | 0 | 0 | 2 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 4 |
| Interferon beta | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
| Histamine H2 receptor | 3 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| GABA theta subunit | 2 | 0 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 0 | 3 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| ATP-citrate synthase | 0 | 0 | 0 | 1 |
| Ribonuclease T | 0 | 0 | 0 | 1 |
| Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Eyes absent homolog 2 | 0 | 2 | 0 | 2 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
| Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| galactokinase | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
| POsterior Segregation | 0 | 0 | 2 | 2 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Polycomb protein EED | 0 | 0 | 1 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| NAD kinase | 0 | 2 | 1 | 3 |
| Dihydrofolate reductase | 0 | 0 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 4 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Hepatocyte growth factor receptor | 0 | 2 | 0 | 2 |
| Matrilysin | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Alpha-amylase 1A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 2 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 2 | 1 | 3 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| CPG DNA methylase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 3 | 5 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 0 | 1 | 0 | 1 |
| Lactoperoxidase | 0 | 0 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 2 | 2 |
| Carbonic anhydrase | 0 | 5 | 0 | 5 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| polyprotein | 2 | 0 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 1 | 5 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 3 |
| D(4) dopamine receptor | 0 | 2 | 1 | 5 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 2 | 1 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 4 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 2 | 0 | 2 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Chain A, Pyruvate kinase, M2 isozyme | 0 | 1 | 0 | 1 |
| Chain A, Phosphonopyruvate hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Phosphoenolpyruvate-protein phosphotransferase | 0 | 1 | 0 | 1 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
| Ornithine transcarbamylase, mitochondrial | 0 | 1 | 0 | 1 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Fe(3+)-Zn(2+) purple acid phosphatase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |